Search

Search Constraints

You searched for: Author/Creator Sulkowski, Mark

Search Results

1. 1223Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis. (December 2014)

3. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. (April 2022)

4. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therapy use. Issue 1 (16th May 2022)

5. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV‐HIV Co‐infected Adults in North America. Issue 3 (25th August 2021)

6. Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals. (12th May 2015)

8. Center‐level trends in utilization of HCV‐exposed donors for HCV‐uninfected kidney and liver transplant recipients in the United States. Issue 8 (9th April 2019)

10. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014)